VHL regulates the sensitivity of clear cell renal cell carcinoma to SIRT4-mediated metabolic stress via HIF-1α/HO-1 pathway

Abstract Clear cell renal cell carcinomas (ccRCC) reprogram carbon metabolism responses to hypoxia, thereby promoting utilization of glutamine. Recently, sirtuin 4 (SIRT4), a novel molecular has turned out to be related to alternating glutamine metabolism and modulating the tumor microenvironment. H...

Full description

Bibliographic Details
Main Authors: Ying Tong, Jinyan Kai, Shuo Wang, Yiwen Yu, Suhong Xie, Hui Zheng, Yanchun Wang, Yixuan Liu, Keyu Zhu, Xiaolin Guan, Lin Guo, Renquan Lu
Format: Article
Language:English
Published: Nature Publishing Group 2021-06-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-021-03901-7
_version_ 1819025122529378304
author Ying Tong
Jinyan Kai
Shuo Wang
Yiwen Yu
Suhong Xie
Hui Zheng
Yanchun Wang
Yixuan Liu
Keyu Zhu
Xiaolin Guan
Lin Guo
Renquan Lu
author_facet Ying Tong
Jinyan Kai
Shuo Wang
Yiwen Yu
Suhong Xie
Hui Zheng
Yanchun Wang
Yixuan Liu
Keyu Zhu
Xiaolin Guan
Lin Guo
Renquan Lu
author_sort Ying Tong
collection DOAJ
description Abstract Clear cell renal cell carcinomas (ccRCC) reprogram carbon metabolism responses to hypoxia, thereby promoting utilization of glutamine. Recently, sirtuin 4 (SIRT4), a novel molecular has turned out to be related to alternating glutamine metabolism and modulating the tumor microenvironment. However, the role of SIRT4 in ccRCC remains poorly understood. Here, we illustrated that the expression of SIRT4 is markedly reduced in cancerous tissues, and closely associated with malignancy stage, grade, and prognosis. In ccRCC cells, SIRT4 exerted its proapoptotic activity through enhancing intracellular reactive oxygen species (ROS). Heme oxygenase-1 (HO-1) is part of an endogenous defense system against oxidative stress. Nevertheless, overexpression of SIRT4 hindered the upregulation of HO-1 in von Hippel–Lindau (VHL)-proficient cells and repressed its expression in VHL-deficient cells. This discrepancy indicated that competent VHL withstands the inhibitory role of SIRT4 on HIF-1α/HO-1. Functionally, overexpression of HO-1 counteracted the promotional effects of SIRT4 on ROS accumulation and apoptosis. Mechanistically, SIRT4 modulates ROS and HO-1 expression via accommodating p38-MAPK phosphorylation. By contrast, downregulation of p38-MAPK by SB203580 decreased intracellular ROS level and enhanced the expression of HO-1. Collectively, this work revealed a potential role for SIRT4 in the stimulation of ROS and the modulation of apoptosis. SIRT4/HO-1 may act as a potential therapeutic target, especially in VHL-deficient ccRCCs.
first_indexed 2024-12-21T05:05:40Z
format Article
id doaj.art-8a5c2676bc93491f92ad54a3aa26a62b
institution Directory Open Access Journal
issn 2041-4889
language English
last_indexed 2024-12-21T05:05:40Z
publishDate 2021-06-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj.art-8a5c2676bc93491f92ad54a3aa26a62b2022-12-21T19:15:08ZengNature Publishing GroupCell Death and Disease2041-48892021-06-0112711310.1038/s41419-021-03901-7VHL regulates the sensitivity of clear cell renal cell carcinoma to SIRT4-mediated metabolic stress via HIF-1α/HO-1 pathwayYing Tong0Jinyan Kai1Shuo Wang2Yiwen Yu3Suhong Xie4Hui Zheng5Yanchun Wang6Yixuan Liu7Keyu Zhu8Xiaolin Guan9Lin Guo10Renquan Lu11Department of Clinical Laboratory, Fudan University Shanghai Cancer CenterDepartment of Clinical Laboratory, Fudan University Shanghai Cancer CenterDepartment of Orthopaedics, Shanghai Jiaotong University Affiliated Sixth People’s HospitalDepartment of Clinical Laboratory, Fudan University Shanghai Cancer CenterDepartment of Clinical Laboratory, Fudan University Shanghai Cancer CenterDepartment of Clinical Laboratory, Fudan University Shanghai Cancer CenterDepartment of Clinical Laboratory, Fudan University Shanghai Cancer CenterDepartment of Clinical Laboratory, Fudan University Shanghai Cancer CenterDepartment of Clinical Laboratory, Fudan University Shanghai Cancer CenterDepartment of Clinical Laboratory, Fudan University Shanghai Cancer CenterDepartment of Clinical Laboratory, Fudan University Shanghai Cancer CenterDepartment of Clinical Laboratory, Fudan University Shanghai Cancer CenterAbstract Clear cell renal cell carcinomas (ccRCC) reprogram carbon metabolism responses to hypoxia, thereby promoting utilization of glutamine. Recently, sirtuin 4 (SIRT4), a novel molecular has turned out to be related to alternating glutamine metabolism and modulating the tumor microenvironment. However, the role of SIRT4 in ccRCC remains poorly understood. Here, we illustrated that the expression of SIRT4 is markedly reduced in cancerous tissues, and closely associated with malignancy stage, grade, and prognosis. In ccRCC cells, SIRT4 exerted its proapoptotic activity through enhancing intracellular reactive oxygen species (ROS). Heme oxygenase-1 (HO-1) is part of an endogenous defense system against oxidative stress. Nevertheless, overexpression of SIRT4 hindered the upregulation of HO-1 in von Hippel–Lindau (VHL)-proficient cells and repressed its expression in VHL-deficient cells. This discrepancy indicated that competent VHL withstands the inhibitory role of SIRT4 on HIF-1α/HO-1. Functionally, overexpression of HO-1 counteracted the promotional effects of SIRT4 on ROS accumulation and apoptosis. Mechanistically, SIRT4 modulates ROS and HO-1 expression via accommodating p38-MAPK phosphorylation. By contrast, downregulation of p38-MAPK by SB203580 decreased intracellular ROS level and enhanced the expression of HO-1. Collectively, this work revealed a potential role for SIRT4 in the stimulation of ROS and the modulation of apoptosis. SIRT4/HO-1 may act as a potential therapeutic target, especially in VHL-deficient ccRCCs.https://doi.org/10.1038/s41419-021-03901-7
spellingShingle Ying Tong
Jinyan Kai
Shuo Wang
Yiwen Yu
Suhong Xie
Hui Zheng
Yanchun Wang
Yixuan Liu
Keyu Zhu
Xiaolin Guan
Lin Guo
Renquan Lu
VHL regulates the sensitivity of clear cell renal cell carcinoma to SIRT4-mediated metabolic stress via HIF-1α/HO-1 pathway
Cell Death and Disease
title VHL regulates the sensitivity of clear cell renal cell carcinoma to SIRT4-mediated metabolic stress via HIF-1α/HO-1 pathway
title_full VHL regulates the sensitivity of clear cell renal cell carcinoma to SIRT4-mediated metabolic stress via HIF-1α/HO-1 pathway
title_fullStr VHL regulates the sensitivity of clear cell renal cell carcinoma to SIRT4-mediated metabolic stress via HIF-1α/HO-1 pathway
title_full_unstemmed VHL regulates the sensitivity of clear cell renal cell carcinoma to SIRT4-mediated metabolic stress via HIF-1α/HO-1 pathway
title_short VHL regulates the sensitivity of clear cell renal cell carcinoma to SIRT4-mediated metabolic stress via HIF-1α/HO-1 pathway
title_sort vhl regulates the sensitivity of clear cell renal cell carcinoma to sirt4 mediated metabolic stress via hif 1α ho 1 pathway
url https://doi.org/10.1038/s41419-021-03901-7
work_keys_str_mv AT yingtong vhlregulatesthesensitivityofclearcellrenalcellcarcinomatosirt4mediatedmetabolicstressviahif1aho1pathway
AT jinyankai vhlregulatesthesensitivityofclearcellrenalcellcarcinomatosirt4mediatedmetabolicstressviahif1aho1pathway
AT shuowang vhlregulatesthesensitivityofclearcellrenalcellcarcinomatosirt4mediatedmetabolicstressviahif1aho1pathway
AT yiwenyu vhlregulatesthesensitivityofclearcellrenalcellcarcinomatosirt4mediatedmetabolicstressviahif1aho1pathway
AT suhongxie vhlregulatesthesensitivityofclearcellrenalcellcarcinomatosirt4mediatedmetabolicstressviahif1aho1pathway
AT huizheng vhlregulatesthesensitivityofclearcellrenalcellcarcinomatosirt4mediatedmetabolicstressviahif1aho1pathway
AT yanchunwang vhlregulatesthesensitivityofclearcellrenalcellcarcinomatosirt4mediatedmetabolicstressviahif1aho1pathway
AT yixuanliu vhlregulatesthesensitivityofclearcellrenalcellcarcinomatosirt4mediatedmetabolicstressviahif1aho1pathway
AT keyuzhu vhlregulatesthesensitivityofclearcellrenalcellcarcinomatosirt4mediatedmetabolicstressviahif1aho1pathway
AT xiaolinguan vhlregulatesthesensitivityofclearcellrenalcellcarcinomatosirt4mediatedmetabolicstressviahif1aho1pathway
AT linguo vhlregulatesthesensitivityofclearcellrenalcellcarcinomatosirt4mediatedmetabolicstressviahif1aho1pathway
AT renquanlu vhlregulatesthesensitivityofclearcellrenalcellcarcinomatosirt4mediatedmetabolicstressviahif1aho1pathway